Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

5th Precision Medicine and Biomarkers Leaders Summit: Europe

5th Precision Medicine and Biomarkers Leaders Summit: Europe

Health Europa listened to InnVentis CEO Thomas Wilckens discuss some of the diagnostic and data challenges involved in precision medicine. The 5th Precision Medicine and...
Michael Lisanti and antibiotics: the next cancer revolution

Michael Lisanti and antibiotics: the next cancer revolution

Speaking to Health Europa, Professor Michael Lisanti, MD-PhD, FRSA discusses the potential role of antibiotics in preventing the recurrence of cancer. How would you cure...
From highly priced medicines to Medicines That Matter

From highly priced medicines to Medicines That Matter

Highly priced medicines represent a significant public health challenge. Global health advocate Ella Weggen shares how Wemos is responding through its dedicated project Medicines...
BioBlocks, Inc. are changing the game of drug discovery

BioBlocks, Inc.: Transforming the process of lead discovery

BioBlocks CEO Dr Peter Pallai discusses how BioBlocks is making drug discovery more straightforward, faster and more economical using data-driven approaches. BioBlocks is a medicinal...
Open Targets – transforming drug discovery

Open Targets – transforming drug discovery

Health Europa talks with Open Targets who discuss how the platform works to systematically identify and prioritise drug discovery to develop safe and effective...
Cocaine contaminant, levamisole, may cause brain damage

Cocaine contaminant, levamisole, may cause brain damage

Individuals who regularly take the cocaine contaminant, levamisole, demonstrate impaired cognitive performance & a thinned prefrontal cortex. Recent findings from the University of Zurich, Switzerland, indicate...
Prudenta: an electronic solution for local literature monitoring in pharmacovigilance

Prudenta: an electronic solution for local literature monitoring in pharmacovigilance

Dr Polina Dombure, the managing director of Inpharmatis, introduces Prudenta, an innovative pharmacovigilance solution set to transform local literature monitoring. The costly, time-consuming and error-prone...
Assessing the environmental risk of pharmaceuticals

Assessing the environmental risk of pharmaceuticals

AstraZeneca’s Jason Snape, outlined his company’s approach to the environmental risk assessment of human medicinal products and what more needs to be in place...
Challenges and opportunities in cancer drug development

Challenges and opportunities in cancer drug development

Managing director Professor Heinz Zwierzina of the Cancer Drug Development Forum talks Health Europa through the challenges in the search for new cancer drugs. The...
Pharmacovigilance in the EU: a closer look at EudraVigilance

Pharmacovigilance in the EU: a closer look at EudraVigilance

Health Europa highlights the role of EudraVigilance in the pharmacovigilance activities of the EMA, from the launch of the revamped system in 2017 to...
Learning from Nature understanding sustainable antibiotic use

Learning from Nature: understanding sustainable antibiotic use

There is a pressing need to better understand sustainable antibiotic use and the evolution of resistance in infectious diseases. The evolution of antibiotic-resistant pathogens poses...
Michael Lisanti and his focus on doxycycline antibiotics

Michael Lisanti and his focus on doxycycline antibiotics

Health Europa delves further into Lisanti’s successful breast cancer clinical trial and the remarkable use of doxycycline antibiotics. Lisanti and his wife Professor Sotgia, from...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest